Document is current
Any future updates will be listed below
-
Authors
Weberpals, Janick https://orcid.org/0000-0003-0404-7394
Jansen, Lina
Haefeli, Walter E.
Hoffmeister, Michael
Wolkewitz, Martin
Herk-Sukel, Myrthe P. P. van
Vissers, Pauline A. J.
Brenner, Hermann
- License Information
-
More Information
Article History
Received: 9 January 2017
Accepted: 20 April 2017
First Online: 6 June 2017
Competing Interests
: J.W., L.J., M.H., P.V. and M.W. have nothing to disclaim. H.B. reports grants from the German Cancer Aid and from German Federal Ministry of Education and Research, during the conduct of the study. M.H.S. is an employee of the PHARMO Institute for Drug Outcomes Research; this independent research institute performs financially supported studies for government and related healthcare authorities and several pharmaceutical companies. W.H. reports personal fees and non-financial support from Aqua Institute Göttingen, Aspen Europe GmbH, Diaplan, EvalueScience Ltd., Grünenthal GmbH, GSK GER/UK/Slovakia/France/Espana/Poland, and Novartis, other from Dosing GmbH, personal fees from Actelion GmbH, AstraZenica GmbH, Berlin-Chemie AG, Boehringer GmbH, Bristol-Myers Squibb GmbH, Gesundheitsamt Österreich, KWHC GmbH, MSD Sharp & Dohme GmbH, Roche, UK, and Südwestrundfunk, personal fees and other from Thieme Verlag and Daiichi Sankyo GmbH, grants and personal fees from Landesapothekerkammer Hessen/Nieders/BW, grants from BMBF (DZIF, ESTHER), EU (QUALMAT), outside the submitted work; and WEH is a member of the scientific advisory board and shareholder of Dosing GmbH, the company distributing the clinical decision support software used in this study. His wife is an employee of Dosing GmbH.
